Web Results



Mecasermin (INN) (trade name Increlex) is recombinant human insulin-like growth factor 1 (IGF-I), which is used for the long-term treatment of growth failure in ...

Mecasermin: Indications, Side Effects, Warnings - Drugs.com


May 2, 2016 ... Easy to read patient leaflet for mecasermin. Includes indications, proper use, special instructions, precautions, and possible side effects.

Mecasermin (Subcutaneous Route) Description and Brand Names ...


Apr 1, 2015 ... Mecasermin injection is a man-made version of insulin-like growth factor-1 (IGF-1 ) hormone. IGF-1 is produced in the liver and plays an ...

DrugBank: Mecasermin


May 16, 2007 ... Mecasermin contains recombinant-DNA-engineered human insulin-like growth factor-1 (rhIGF-1). IGF-1 consists of 70 amino acids in a single ...

DailyMed - INCRELEX- mecasermin injection, solution


1.1 Severe Primary IGF-1 Deficiency (Primary IGFD) INCRELEX® (mecasermin [ rDNA origin] injection) is indicated for the treatment of: growth failure in .

Mecasermin (Increlex®) - Texas Medicaid/CHIP Vendor Drug Program


Mecasermin (Increlex®). [Developed, December 2006; Revised, May 2007; May 2010; June 2010; February 2012; December 2013]. MEDICAID DRUG USE ...

Insulin-Like Growth Factor-1 (IGF-1) Analogues: Mecasermin ... - Aetna


Aetna considers mecasermin (Increlex) and mecasermin rinfabate (Iplex)* medically necessary for the treatment of growth failure in children with severe primary ...

INCRELEX, INN: mecasermin - European Medicines Agency


INCRELEX (mecasermin) is recombinant human insulin-like growth factor-1 ... Mecasermin was granted orphan status in the EU for “Treatment of growth ...

Increlex (mecasermin) Drug Side Effects, Interactions, and ...


Drug information on Increlex (mecasermin), includes drug pictures, side effects, drug interactions, directions for use, symptoms of overdose, and what to avoid.

Mecasermin - US Family Health Plan


Mecasermin [rDNA origin] injection (Increlex) is used for the long-term treatment of growth failure in children with severe primary insulin-like growth factor (IGF)-1  ...

More Info

Increlex (mecasermin) - CenterWatch


Increlex (mecasermin): For the treatment of growth failure due to Primary IGFD. New approved drug details including side effects, uses and general information.



Manufacturer's information about recombinant human insulin-like growth factor-1, marketed under the brand name Increlex (generic name mecasermin).

Mecasermin (recombinant human insulin-like growth factor I). - NCBI


Adv Ther. 2009 Jan;26(1):40-54. doi: 10.1007/s12325-008-0136-5. Epub 2009 Jan 28. Mecasermin (recombinant human insulin-like growth factor I).